TORONTO, Aug. 27, 2018 /CNW/ - Pure Global Cannabis Inc.
(TSX.V:PURE; OTC: PRCNF) (the "Company" or "Pure Global" or "PURE"), a vertically-integrated,
growth-oriented life sciences cannabis company, is pleased to announce that its wholly-owned subsidiary, PureSinse Inc.
("PureSinse"), has received approval for an amendment to its licence from Health Canada under the Access to
Cannabis for Medical Purposes Regulations ("ACMPR"), to include the activity of possession of cannabis oil,
resin, and relevant activities.
PureSinse's license under the ACMPR was amended August 24, 2018, allowing the company to source
bulk psychoactive and non-psychoactive cannabis oils along with resins from national and international licensed producers that
meet Pure Global's high quality standards. The next step will be to receive Health Canada approvals to process, package, and sell
cannabis oil-based products.
The Company anticipates that PureSinse will be granted a cannabis oils production and processing licence by the end of 2018
and subsequent oils sales licence in early 2019. Upon final licensing approval, PureSinse will have the ability to sell cannabis
oil products to registered patients under the ACMPR, for adult legal use under the Cannabis Act, and for export purposes,
along with its current dried medical cannabis products.
"This license is instrumental for PURE's ability to initiate revenue generation from oils in the coming quarters, while
driving our product innovation, amplifying our intellectual property portfolio, and propelling our research and development
mandates for cannabis oils-based products. The Company will look to secure long-term supply agreements for bulk dried flower,
extractable trim, and now for cannabis and cannabidiol (CBD) distillates, isolates, and extracts, for processing, packaging, and
distribution," said Pure Global President & CEO Malay Panchal. "We will immediately be applying for our oils production and
processing licences to accelerate the development and formulation of cannabis oils products such as gel capsules, tinctures,
sublinguals, and transdermal dosage forms," added Mr. Panchal.
About Pure Global Cannabis
Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF) is a vertically-integrated, growth-oriented life sciences cannabis
company led by experienced pharma-industry, horticultural, consumer packaged goods (CPG), and supply chain experts. The Company's
wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Access to Cannabis for Medical Purposes
Regulations (ACMPR) focused on producing cannabis products for medical, wellness, health & beauty, natural health, and
future legal adult use markets.
To register to Pure Global's mailing list, please visit www.pureglobal.com. Follow @pureglobalcanna on Twitter and Facebook and
@pureglobalcannabis on Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains certain forward-looking statements, including, but not limited to, statements about Pure Global's
future plans and intentions. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend",
"anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words, or similar
words or phrases, have been used to identify these forward-looking statements. These statements reflect management's current
beliefs and are based on information currently available to management as at the date hereof.
Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results,
performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These
factors should be considered carefully, and readers should not place undue reliance on the forward-looking statements. Although
the forward-looking statements contained in this news release are based upon what management believes to be reasonable
assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements.
These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or
revise them to reflect new events or circumstances, except as required by law.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts
responsibility for the adequacy or accuracy of this release.
SOURCE Pure Global Cannabis Inc.
View original content with multimedia: http://www.newswire.ca/en/releases/archive/August2018/27/c1153.html